Slingshot members are tracking this event:

AstraZeneca (AZN) earns FDA approval for Qtern for adults with type 2 diabetes who cannot control blood sugar with saxagliptin, dapagliflozin

Do you think this event is important to the companies below? How will it affect their stock price?

Related Companies
High Medium Low
Impact on Stocks
AZN Community voting in process
Slingshot Insights Explained
Catalyst Date
Occurred on:
Mar 01, 2017
Related Projects Image
  • Don’t see a project related to the catalyst you care about?

Related Keywords Dapagliflozin, Fda Approval, Qtern, Adults With Type 2 Diabetes, Saxagliptin